122 related articles for article (PubMed ID: 3709643)
1. Isosorbide dinitrate in plasma and dialysate during haemodialysis.
Bauer H; Laufen H; Franz HE
Eur J Clin Pharmacol; 1986; 30(2):187-90. PubMed ID: 3709643
[TBL] [Abstract][Full Text] [Related]
2. Lack of bioequivalence between different formulations of isosorbide dinitrate and hydralazine and the fixed-dose combination of isosorbide dinitrate/hydralazine: the V-HeFT paradox.
Tam SW; Sabolinski ML; Worcel M; Packer M; Cohn JN
Clin Pharmacokinet; 2007; 46(10):885-95. PubMed ID: 17854237
[TBL] [Abstract][Full Text] [Related]
3. [Concentration-time profile of isosorbide dinitrate and its metabolites in plasma following percutaneous resorption of a transdermal therapeutic system].
Menke G; Schnellhammer R; Rietbrock N
Arzneimittelforschung; 1987 Nov; 37(11):1301-3. PubMed ID: 3440041
[TBL] [Abstract][Full Text] [Related]
4. Sex-related difference in the metabolism of isosorbide dinitrate following incubation in human blood.
Bennett BM; Twiddy DA; Moffat JA; Armstrong PW; Marks GS
Biochem Pharmacol; 1983 Dec; 32(24):3729-34. PubMed ID: 6661248
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics and metabolism of isosorbide-dinitrate after intravenous and oral administration.
Abshagen U; Betzien G; Endele R; Kaufmann B; Neugebauer G
Eur J Clin Pharmacol; 1985; 27(6):637-44. PubMed ID: 3987768
[TBL] [Abstract][Full Text] [Related]
6. Nitrate tolerance: hemodynamic effects of intravenous isosorbide dinitrate after sustained oral isosorbide dinitrate administration.
Kumagae H; Koiwaya Y; Tanaka K
Clin Ther; 1990; 12(1):31-43. PubMed ID: 2328526
[TBL] [Abstract][Full Text] [Related]
7. Bioavailability and metabolism of isosorbide dinitrate from a transdermal spray.
Laufen H; Leitold M
Arzneimittelforschung; 1992 Jul; 42(7):931-5. PubMed ID: 1418058
[TBL] [Abstract][Full Text] [Related]
8. [Plasma levels of isosorbide dinitrate and its metabolites during intravenous infusion in surgical patients--effect of preoperative administration of isosorbide dinitrate].
Murakawa T; Hashimoto Y; Sato T; Takagi H; Kushikata T; Araki I; Kou H; Kimura F; Matsuki A
Masui; 1993 Feb; 42(2):225-32. PubMed ID: 8437354
[TBL] [Abstract][Full Text] [Related]
9. Plasma disposition and hemodynamic effects of a single oral dose of isosorbide dinitrate in human males and females.
Nakatsu K; Brien JF; Savard G; Toffelmire EB; Abdollah H; Bennett BM; Marks GS
Biopharm Drug Dispos; 1992 Jul; 13(5):357-67. PubMed ID: 1498268
[TBL] [Abstract][Full Text] [Related]
10. Serum concentrations of isosorbide dinitrate produced by a sustained-release capsule.
Halkin H; Almog S; Friedman E
Isr J Med Sci; 1979 May; 15(5):448-50. PubMed ID: 447513
[TBL] [Abstract][Full Text] [Related]
11. [Comparative study of the bioavailability and pharmacokinetics of isosorbide dinitrate formulations in retard form and in standard preparations by determination of isosorbide-5-mononitrate].
Lutz VD; Gielsdorf W; Rasper J; Jaeger H; Loew D
Arzneimittelforschung; 1985; 35(4):730-4. PubMed ID: 4015739
[TBL] [Abstract][Full Text] [Related]
12. Bioavailability of isosorbide dinitrate and its two mononitrate metabolites from sustained-release formulations.
Chasseaud LF; Doyle E; Taylor T; Darragh A; Lambe RF
Int J Clin Pharmacol Ther Toxicol; 1983 Oct; 21(10):514-8. PubMed ID: 6642789
[TBL] [Abstract][Full Text] [Related]
13. Isosorbide dinitrate bioavailability, kinetics, and metabolism.
Straehl P; Galeazzi RL
Clin Pharmacol Ther; 1985 Aug; 38(2):140-9. PubMed ID: 4017416
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of isosorbide dinitrate.
Fung HL
Am Heart J; 1985 Jul; 110(1 Pt 2):213-6. PubMed ID: 4013997
[TBL] [Abstract][Full Text] [Related]
15. Plasma concentrations of isosorbide dinitrate after oral administration of a sustained-release formulation to human subjects.
Assinder DF; Chasseaud LF; Hunter JO; Jung RJ; Taylor T
Arzneimittelforschung; 1977; 27(1):156-8. PubMed ID: 576817
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of intravenous isosorbide-dinitrate.
Platzer R; Reutemann G; Galeazzi RL
J Pharmacokinet Biopharm; 1982 Dec; 10(6):575-86. PubMed ID: 7182455
[TBL] [Abstract][Full Text] [Related]
17. Hepatic extraction of isosorbide dinitrate in cardiac patients.
Morrison RA; Wiegand UW; Jähnchen E; Höhmann D; Kasper W; Meinertz T; Fung HL
Clin Pharmacol Ther; 1983 Dec; 34(6):724-31. PubMed ID: 6641086
[TBL] [Abstract][Full Text] [Related]
18. Bioavailability and pharmacokinetics of a new isosorbide dinitrate spray preparation in healthy volunteers.
Hutt V; Theodor R; Pabst G; Lutz D; Bonn R; Fritschi E
Arzneimittelforschung; 1993 Aug; 43(8):842-6. PubMed ID: 8216439
[TBL] [Abstract][Full Text] [Related]
19. Oral absorption and disposition of isosorbide dinitrate and isosorbide mononitrates in man.
Laufen H; Aumann M; Leitold M
Arzneimittelforschung; 1983; 33(7):980-4. PubMed ID: 6684933
[TBL] [Abstract][Full Text] [Related]
20. Comparative pharmacokinetics of isosorbide nitrates after repeated doses of sustained release isosorbide dinitrate.
Laufen H; Leitold M; Wildfeuer A
Arzneimittelforschung; 1988 Sep; 38(9):1336-41. PubMed ID: 3223973
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
